2010 CBER Approvals
In our slideshow on the 2010 FDA approvals, we looked at the 21 drugs approved by the CDER last year. But there were five other notable drugs approved by the Center for Biologics Evaluation and Research (CBER)--including the highly-anticipated prostate cancer drug Provenge--that were also new to the market this year. Click here to begin the slideshow
Comments